Results 41 to 50 of about 2,826 (214)

Factors associated with patients’ mobility rates within the provinces of Iran

open access: yesBMC Health Services Research, 2022
Background The absence of a referral system and patients’ freedom to choose among service providers in Iran have led to increased patient mobility, which continues to concern health policymakers in the country.
Somayeh Noori Hekmat   +5 more
doaj   +1 more source

Ironic Medications: A Narrative‐Based Psycho‐Educational Intervention to Explore Patient–Provider Communication in Adolescents With Haematological Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Adolescents with haematological malignancies face significant emotional and relational challenges, often accompanied by difficulties in communicating their needs within the healthcare context. To address these issues, a narrative‐based psycho‐educational intervention based on the creation and prescription of Ironic Medications was ...
Marta Stoppa   +7 more
wiley   +1 more source

Comparing and modeling the use of online recommender systems

open access: yesComputers in Human Behavior Reports
This study explores a new way to model the adoption of AI, specifically online recommender systems. It aims to find factors that can explain the variation in usage in terms of differences between individuals and differences over technologies. We analyzed
Emma Engström   +4 more
doaj   +1 more source

Incidence and Severity of Carboplatin‐Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla   +6 more
wiley   +1 more source

Regulating high-reach AI: On transparency directions in the Digital Services Act

open access: yesInternet Policy Review
By introducing the concept of high-reach AI, this paper focuses on AI systems whose widespread use may generate significant risks for both individuals and societies.
Kasia Söderlund   +4 more
doaj   +1 more source

Feeling the future: An exploration into studying youth futures

open access: yesFutures
The aim of this paper is to offer a contribution in the search for appropriate ways to disentangle the intangibility of the future – especially amongst young people, who have been hit particularly hard by the Covid-19 pandemic. It draws on a large research project which investigates how young people in several Italian cities look at their futures ...
Mandich, G., Satta, C., Cuzzocrea, V.
openaire   +1 more source

Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with recurrent diffuse midline gliomas (DMGs) have limited therapeutic options at recurrence. Re‐irradiation (RT2) may be used at progression, but with uncertainty about the benefit. Methods We conducted a multi‐institutional retrospective study of children aged < 18 with DMG treated at three centers (Toronto, Canada ...
Ajay Thomas Alex   +13 more
wiley   +1 more source

Designing Robust Prioritization Paradigm Focusing on Strategic Industries [PDF]

open access: yesبهبود مدیریت, 2015
The conventional method for prioritizing in Futures Studies, is a methodology of key technologies in which with the attractiveness and feasibility criteria and via the expertbased process, options with greater priority are distinguished from each other ...
Mahdi Ahmadian   +2 more
doaj  

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko   +19 more
wiley   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy